| Growth factor therapy to improve soft tissue healing. | |
| | |
MedLine Citation:
|
PMID: 11823932 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The advent of new U.S. Food and Drug Administration-approved products containing growth factors to improve soft tissue healing signifies a new era for wound healing. Over the last decade, some clinical growth factor studies have been promising, whereas others have not shown any positive effect. What many of these studies have shown is that the state of a healing wound is not only dependent on its growth factor milieu but also on other variables (wound care, tissue oxygen state, bacteria count, and nutritional status of the patient). This article describes recent progress with growth factors on soft tissue structures (skin, mucosa, and nerve) relevant to the facial plastic and reconstructive surgeon. |
| | |
Authors:
|
David B Hom; Gentry Thatcher; Robert Tibesar |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review |
Journal Detail:
|
Title: Facial plastic surgery : FPS Volume: 18 ISSN: 0736-6825 ISO Abbreviation: Facial Plast Surg Publication Date: 2002 Feb |
Date Detail:
|
Created Date: 2002-02-01 Completed Date: 2002-06-04 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 8405303 Medline TA: Facial Plast Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 41-52 Citation Subset: D |
Affiliation:
|
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, University of Minnesota School of Medicine and Hennepin County Medical Center, Minneapolis, MN 55455, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Growth Substances / pharmacology*, therapeutic use* Humans Mucous Membrane / injuries Peripheral Nerves / injuries Reconstructive Surgical Procedures* Skin / injuries Soft Tissue Injuries / therapy* Wound Healing / drug effects* |
| Grant Support | |
ID/Acronym/Agency:
|
DE12005/DE/NIDCR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Growth Substances |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Botulinum toxin to minimize facial scarring.
Next Document: Gene therapy, electroporation, and the future of wound-healing therapies.